These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33268766)

  • 1. Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder.
    Duarte-Silva E; Maes M; Macedo D; Savino W; Peixoto CA
    Transl Psychiatry; 2020 Dec; 10(1):419. PubMed ID: 33268766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease.
    Choudhuri S; Garg NJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33172999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system commitment in Chagas disease.
    Useche Y; Pérez AR; de Meis J; Bonomo A; Savino W
    Front Immunol; 2022; 13():975106. PubMed ID: 36439149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress implications for therapeutic vaccine development against Chagas disease.
    Choudhuri S; Rios L; Vázquez-Chagoyán JC; Garg NJ
    Expert Rev Vaccines; 2021 Nov; 20(11):1395-1406. PubMed ID: 34406892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways.
    Machado-Silva A; Cerqueira PG; Grazielle-Silva V; Gadelha FR; Peloso Ede F; Teixeira SM; Machado CR
    Mutat Res Rev Mutat Res; 2016; 767():8-22. PubMed ID: 27036062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
    Vilar-Pereira G; Silva AA; Pereira IR; Silva RR; Moreira OC; de Almeida LR; de Souza AS; Rocha MS; Lannes-Vieira J
    Brain Behav Immun; 2012 Oct; 26(7):1136-49. PubMed ID: 22841695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved.
    Lannes-Vieira J; Vilar-Pereira G; Barrios LC; Silva AA
    Mem Inst Oswaldo Cruz; 2023; 118():e220287. PubMed ID: 37018799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine colon organoids as a novel model to study
    Daghero H; Pagotto R; Quiroga C; Medeiros A; Comini MA; Bollati-Fogolín M
    Front Cell Infect Microbiol; 2023; 13():1082524. PubMed ID: 36968103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.
    Beltran-Hortelano I; Alcolea V; Font M; Pérez-Silanes S
    Bioorg Med Chem; 2022 Mar; 58():116577. PubMed ID: 35189560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue.
    Vilar-Pereira G; Castaño Barrios L; Silva AAD; Martins Batista A; Resende Pereira I; Cruz Moreira O; Britto C; Mata Dos Santos HA; Lannes-Vieira J
    PLoS One; 2021; 16(1):e0244710. PubMed ID: 33400707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of oxidative stress in adipose tissue during Trypanosoma cruzi infection.
    Wen JJ; Nagajyothi F; Machado FS; Weiss LM; Scherer PE; Tanowitz HB; Garg NJ
    Parasitol Res; 2014 Sep; 113(9):3159-65. PubMed ID: 24948102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual and Opposite Roles of Reactive Oxygen Species (ROS) in Chagas Disease: Beneficial on the Pathogen and Harmful on the Host.
    Maldonado E; Rojas DA; Morales S; Miralles V; Solari A
    Oxid Med Cell Longev; 2020; 2020():8867701. PubMed ID: 33376582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi infection results in an increase in intracellular cholesterol.
    Johndrow C; Nelson R; Tanowitz H; Weiss LM; Nagajyothi F
    Microbes Infect; 2014 Apr; 16(4):337-44. PubMed ID: 24486184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.
    Piacenza L; Peluffo G; Alvarez MN; Martínez A; Radi R
    Antioxid Redox Signal; 2013 Sep; 19(7):723-34. PubMed ID: 22458250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine modulation, oxidative stress and thymic dysfunctions: Role of age-related changes in the experimental Trypanosoma cruzi infection: Age-related thymic dysfunctions and Trypanosoma cruzi infection.
    Colato RP; Brazão V; do Vale GT; Santello FH; Sampaio PA; Tirapelli CR; Pereira-da-Silva G; Do Prado JC
    Cytokine; 2018 Nov; 111():88-96. PubMed ID: 30130728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood.
    Moraes-Souza H; Bordin JO; Bardossy L; MacPherson DW; Blajchman MA
    Transfusion; 1995 Sep; 35(9):723-6. PubMed ID: 7570930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
    Farani PSG; Begum K; Vilar-Pereira G; Pereira IR; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    Front Cell Infect Microbiol; 2021; 11():692655. PubMed ID: 34381739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.